Keywords: genentics, institute, rhil-11, genetics, begun, phase, iii

Genentics Institute's rhIL-11

Article | 20 November 1995

Print This

Genetics Institute has begun a Phase III trial of its recombinant interleukin-11 for the restoration of platelets after cancer chemotherapy. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in